As shown in Figure 5, we found that in some cancers, especially in LUAD and TGCT, FH expression was significantly correlated with multiple immune checkpoint markers, such as BTLA, TNFRSF14, LAIR1, CD48, and CD28. This evidence concerns the gene TNFRSF14 and cancer.